{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-076330","form_type":"8-K","ticker":null,"cik":"0001394319","company_name":"Tracon Pharmaceuticals, Inc.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.219306+00:00","generated_at":"2026-06-01T02:46:00.334716+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"TRACON gets Nasdaq delisting notice; CBDO resigns","bullets":["Nasdaq Hearings Panel determined to delist TCON common stock effective June 13, 2024 for noncompliance with continued listing requirements.","Trading continues on Nasdaq as of filing date; company expects to move to OTCQB Venture Market under symbol TCON.","David Lazar voluntarily resigned as Chief Business Development Officer effective June 19, 2024; no disagreement with the company."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-076330","json":"https://secwatch.observer/filing/0000950170-24-076330.json","markdown":"https://secwatch.observer/filing/0000950170-24-076330.md","text":"https://secwatch.observer/filing/0000950170-24-076330.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1394319/000095017024076330/0000950170-24-076330-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1394319/000095017024076330/tcon-20240619.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:46:00.334716+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"33666eaa44","claim":"David Lazar resigned as Chief Business Development Officer at Tracon Pharmaceuticals, Inc..","evidence_excerpt":"On June 19, 2024, David Lazar notified the Company that he voluntarily resigned from his position as Chief Business Development Officer of the Company, effective June 19, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1394319/000095017024076330/0000950170-24-076330-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Business Development Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}